These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15987478)
1. A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat. Keith JC; Sainz IM; Isordia-Salas I; Pixley RA; Leathurby Y; Albert LM; Colman RW Arthritis Res Ther; 2005; 7(4):R769-76. PubMed ID: 15987478 [TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420 [TBL] [Abstract][Full Text] [Related]
3. Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats. Kerr SW; Wolyniec WW; Filipovic Z; Nodop SG; Braza F; Winquist RJ; Noonan TC J Pharmacol Exp Ther; 1999 Nov; 291(2):903-10. PubMed ID: 10525115 [TBL] [Abstract][Full Text] [Related]
4. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950 [TBL] [Abstract][Full Text] [Related]
5. CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. May E; Dorris ML; Satumtira N; Iqbal I; Rehman MI; Lightfoot E; Taurog JD J Immunol; 2003 Jan; 170(2):1099-105. PubMed ID: 12517979 [TBL] [Abstract][Full Text] [Related]
6. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor. Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912 [TBL] [Abstract][Full Text] [Related]
7. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin. Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the new anti-inflammatory agent, IS-741, on spontaneous colitis in HLA-B27/beta2-microglobulin transgenic rats. Makino J; Andoh A; Hata K; Yotsuya S; Shikama H; Imamura M; Fujiyama Y; Bamba T J Gastroenterol Hepatol; 2002 Aug; 17(8):854-60. PubMed ID: 12164961 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755 [TBL] [Abstract][Full Text] [Related]
10. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats. Venkova K; Keith JC; Greenwood-Van Meerveld B J Pharmacol Exp Ther; 2004 Jan; 308(1):206-13. PubMed ID: 14569059 [TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and kininogen gene expression after acute-phase inflammation. Chao J; Swain C; Chao S; Xiong W; Chao L Biochim Biophys Acta; 1988 Mar; 964(3):329-39. PubMed ID: 3126819 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory disease in HLA-B27 transgenic rats. Taurog JD; Maika SD; Satumtira N; Dorris ML; McLean IL; Yanagisawa H; Sayad A; Stagg AJ; Fox GM; Lê O'Brien A; Rehman M; Zhou M; Weiner AL; Splawski JB; Richardson JA; Hammer RE Immunol Rev; 1999 Jun; 169():209-23. PubMed ID: 10450519 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation. Greenwood-Van Meerveld B; Venkova K; Keith JC J Pharmacol Exp Ther; 2001 Oct; 299(1):58-66. PubMed ID: 11561063 [TBL] [Abstract][Full Text] [Related]
14. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. Taurog JD; Richardson JA; Croft JT; Simmons WA; Zhou M; Fernández-Sueiro JL; Balish E; Hammer RE J Exp Med; 1994 Dec; 180(6):2359-64. PubMed ID: 7964509 [TBL] [Abstract][Full Text] [Related]
15. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. Peterson RL; Wang L; Albert L; Marchese E; Erickson J; Wong A; Mounts WM; Hayes L; Bouchard P; Keith J; Dorner AJ Pharmacogenomics J; 2002; 2(6):383-99. PubMed ID: 12629504 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Harnish DC; Albert LM; Leathurby Y; Eckert AM; Ciarletta A; Kasaian M; Keith JC Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G118-25. PubMed ID: 12958017 [TBL] [Abstract][Full Text] [Related]
18. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Schultz M; Munro K; Tannock GW; Melchner I; Göttl C; Schwietz H; Schölmerich J; Rath HC Clin Diagn Lab Immunol; 2004 May; 11(3):581-7. PubMed ID: 15138186 [TBL] [Abstract][Full Text] [Related]
19. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279 [TBL] [Abstract][Full Text] [Related]
20. Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model. Bowen-Yacyshyn MB; Bennett CF; Nation N; Rayner D; Yacyshyn BR J Pharmacol Exp Ther; 2002 Sep; 302(3):908-17. PubMed ID: 12183646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]